GM

Globus Medical

GMED
NYSEHealth Care
$80.39
USD
-0.13(-0.16%)
At close: Jun 12, 20:00 UTC

Open

$80.41

Prev. Close

$80.45

High

$80.54

Low

$80.29

Market Snapshot

Market Cap

$10.87B

P/E Ratio

18.5

EPS

0.76

Revenue

$2.52B

Why GMED moved

Horizon Investment Services acquired 17,621 shares of Globus Medical, highlighting growing interest from hedge funds in the spinal surgery and medical device industry.

About

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 6,000 full-time employees. The company went IPO on 2012-03-08. The firm provides education and clinical support, and advanced care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. The firm offers a comprehensive portfolio of technologies that address a variety of musculoskeletal pathologies, anatomies, and surgical approaches. The company separates its products and services into two major categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, surgical instruments, spinal cord stimulation treatment therapy, and neuromonitoring services, used in an expansive range of spinal, orthopedic and neurosurgical procedures. Its Enabling Technologies are comprised of imaging, navigation and robotics (INR) solutions for assisted surgery which are advanced computer-assisted intelligent systems designed to enhance a surgeon’s capabilities.

Recently from Cashu